Zhou, Jingran <br/><br/>
A20-binding inhibitor of NF-κB (ABIN1) controls Toll-like receptor-mediated CCAAT/enhancer-binding protein β activation and protects from inflammatory disease.  [electronic resource] 

 -  Proceedings of the National Academy of Sciences of the United States of America  Nov 2011 
 - E998-1006 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1091-6490 
<br/><br/><label>Standard No.: </label>10.1073/pnas.1106232108  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptor Proteins, Signal Transducing--physiology<br/>Animals<br/>Base Sequence<br/>Bone Marrow Cells--physiology<br/>CCAAT-Enhancer-Binding Protein-beta--metabolism<br/>DNA Primers<br/>Fetal Death<br/>Lupus Erythematosus, Systemic--prevention & control<br/>Mice<br/>Mice, Inbred C57BL<br/>NF-kappa B--antagonists & inhibitors<br/>Psoriasis--prevention & control<br/>Signal Transduction<br/>Toll-Like Receptors--physiology